MYCi361

CAS : 2289690-31-7

Ref. 3D-PRD69031

Informations sur le produit

• Nom: MYCi361
• CAS: 2289690-31-7

Description

MYCi361 is an antibody-drug conjugate that targets the histone deacetylase. MYCi361 has been shown to be effective in treating leukocyte antigen (HLA)-expressing tumours, such as melanoma, colorectal cancer, and breast cancer that overexpress the HER2 receptor. MYCi361 blocks the biological activity of histone deacetylase by binding to it, which results in reduced expression of HLA proteins. This leads to tumor regression and prolonged survival in animal models.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 594.9 g/mol
• Formule: C₂₆H₁₆ClF₉N₂O₂
• Degré de pureté: Min. 95%